Invention Grant
US08658181B2 Pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease
有权
用于预防和治疗肝纤维化或非酒精性脂肪性肝病的药物组合物
- Patent Title: Pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease
- Patent Title (中): 用于预防和治疗肝纤维化或非酒精性脂肪性肝病的药物组合物
-
Application No.: US13664550Application Date: 2012-10-31
-
Publication No.: US08658181B2Publication Date: 2014-02-25
- Inventor: Huan Ching Hsu , Ya Chun Wang
- Applicant: TCM Biotech International Corp.
- Applicant Address: TW Taipei
- Assignee: TCM Biotech International Corp.
- Current Assignee: TCM Biotech International Corp.
- Current Assignee Address: TW Taipei
- Agency: Woodard, Emhardt, Moriarty, McNett & Henry LLP
- Priority: TW101110713A 20120328
- Main IPC: A61K36/481
- IPC: A61K36/481 ; A61K36/068 ; A61K36/00 ; A61K36/06
Abstract:
The present invention provides a pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease, comprising 50 to 90% by weight of Cordyceps sinensis mycelium powder, and 10 to 50% by weight of condensed astragalus powder.
Public/Granted literature
Information query
